Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents. 2017

Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
Medicinal Chemistry Division, GVK Biosciences Pvt. Ltd, Plot 28A, IDA Nacharam, Hyderabad, India; JNTUH-College of Engineering, Nachupally, Karimnagar, India.

A robust economic approach to N-(quinazoline-4-yl)sulfonamides was developed and synthesized different aryl, hetero aryl, alkyl and cyclopropyl sulfonamides in excellent yields. All the compounds were evaluated for cytotoxic affinity to SKOV3, DU145, THP1, U937, and COLO205 cell lines. Interesting to find that the bulkiness of substituent at C-2 position of quinazoline forces the molecule to flip around in order to bind in the active site, when compared to the binding preference of previously known quinazoline compounds. Among the 21 compounds synthesized 2b, 2d, 2e, 2h, 2i, 3c, 3d, 3f, 3g and 3h found to be active on all the cell lines tested with IC50 values <10µg/mL. Performed docking simulations to understand the binding preference of various C-2 substituted quinazoline sulfonamides.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
August 2012, Journal of enzyme inhibition and medicinal chemistry,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
April 2013, Journal of enzyme inhibition and medicinal chemistry,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
January 2015, Chemical & pharmaceutical bulletin,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
January 2015, European journal of medicinal chemistry,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
October 2020, Bioorganic & medicinal chemistry letters,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
April 2013, Drug research,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
November 2022, BMC chemistry,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
December 2018, Journal of enzyme inhibition and medicinal chemistry,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
August 2012, European journal of medicinal chemistry,
Suresh Poudapally, and Shankar Battu, and Loka Reddy Velatooru, and Murali Satyanarayana Bethu, and Venkateswara Rao Janapala, and Somesh Sharma, and Subhabrata Sen, and Narender Pottabathini, and Vijaya Bhaskara Reddy Iska, and Vidya Katangoor
July 2004, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!